Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2023-03-30 Remuneration Information
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Terms of Reference of the Remuneration and Appraisal Committee of the Board
Remuneration Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD' and details the responsibilities, composition, procedures, and duties of the Remuneration and Appraisal Committee of Pharmaron Beijing Co., Ltd. It focuses on remuneration policies, appraisal standards, committee meetings, voting, and governance related to executive compensation. There is no financial data, earnings information, or report publication mentioned. The content is clearly about remuneration governance and committee terms rather than a report or announcement. Therefore, the document fits the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2023-03-30 English
PROPOSED GRANT OF THE 2022 CONVERTIBLE BONDS-RELATED SPECIFIC MANDATE TO ISSUE ADDITIONAL H SHARES
Capital/Financing Update Classification · 95% confidence The document is an announcement related to the proposed grant of a specific mandate to issue additional H shares linked to convertible bonds. It discusses adjustments to conversion prices, shareholder approvals required at the 2022 AGM and class meetings, use of proceeds from convertible bonds, and the effect on shareholding structure. The document is not a full financial report but rather a detailed announcement about capital structure changes and shareholder resolutions related to convertible bonds and share issuance. It references the upcoming AGM and shareholder meetings where approval will be sought. The content focuses on capital/financing updates, specifically the issuance of additional shares under convertible bonds and related mandates. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the financing activity, not just a brief notice or a report publication announcement.
2023-03-30 English
FINAL DIVIDEND IN BONUS SHARES FOR THE YEAR ENDED DECEMBER 31, 2022
Share Issue/Capital Change Classification · 95% confidence The document is an announcement titled 'FINAL DIVIDEND IN BONUS SHARES FOR THE YEAR ENDED DECEMBER 31, 2022' by Pharmaron Beijing Co., Ltd. It details the distribution ratio of bonus shares, dates related to shareholders' approval, despatch, dealing, and other administrative details. The document is relatively short (3147 characters) and structured as an announcement rather than a full report. It does not contain financial statements or detailed financial analysis but rather informs shareholders about a bonus share issue related to dividends. This fits the category of a Share Issue/Capital Change announcement, as it concerns the issuance of bonus shares to shareholders.
2023-03-30 English
FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2022
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides details about a final dividend for the year ended December 31, 2022. It includes information such as dividend type, amount, and related dates, although many dates are 'To be announced'. The document is relatively short (3530 characters) and focuses solely on dividend declaration details without containing full financial statements or comprehensive financial performance data. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2023-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022' and contains detailed consolidated financial statements including profit or loss, comprehensive income, financial position, and notes to the consolidated financial statements. It includes extensive financial data for the full fiscal year 2022, comparative figures for 2021, and detailed segment revenue and results. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Annual Report, which covers company activity and full financial performance for the year. Therefore, the document should be classified as an Annual Report (10-K). FY 2022
2023-03-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-03-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.